T1	Participants 58 77	malignant melanoma.
T2	Participants 189 207	malignant melanoma
T3	Participants 400 443	surgery in patients with high-risk melanoma
T4	Participants 458 546	the patients had lesions greater than 1.70 mm thick and TNM stage IB or stage II disease
T5	Participants 613 624	13 patients
T6	Participants 677 688	14 patients
